+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jan 2024 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 94
According to our LPI (LP Information) latest study, the global Traveler's Diarrhea Therapeutics market size was valued at US$ 768.3 million in 2023. With growing demand in downstream market, the Traveler's Diarrhea Therapeutics is forecast to a readjusted size of US$ 1263.5 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Traveler's Diarrhea Therapeutics market. Traveler's Diarrhea Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Traveler's Diarrhea Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Traveler's Diarrhea Therapeutics market.
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
Key Features:
The report on Traveler's Diarrhea Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Traveler's Diarrhea Therapeutics market. It may include historical data, market segmentation by Type (e.g., Immunization, Non-antibiotic Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Traveler's Diarrhea Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Traveler's Diarrhea Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Traveler's Diarrhea Therapeutics industry. This include advancements in Traveler's Diarrhea Therapeutics technology, Traveler's Diarrhea Therapeutics new entrants, Traveler's Diarrhea Therapeutics new investment, and other innovations that are shaping the future of Traveler's Diarrhea Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Traveler's Diarrhea Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Traveler's Diarrhea Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Traveler's Diarrhea Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Traveler's Diarrhea Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Traveler's Diarrhea Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Traveler's Diarrhea Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Traveler's Diarrhea Therapeutics market.
Market Segmentation:
Traveler's Diarrhea Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segmentation by application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Key Questions Addressed in this Report
What is the 10-year outlook for the global Traveler's Diarrhea Therapeutics market?
What factors are driving Traveler's Diarrhea Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Traveler's Diarrhea Therapeutics market opportunities vary by end market size?
How does Traveler's Diarrhea Therapeutics break out type, application?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Traveler's Diarrhea Therapeutics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Traveler's Diarrhea Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Traveler's Diarrhea Therapeutics Segment by Type
2.2.1 Immunization
2.2.2 Non-antibiotic Agents
2.2.3 Antibiotics
2.2.4 Anti-Motility Agents
2.2.5 Others
2.3 Traveler's Diarrhea Therapeutics Sales by Type
2.3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2024)
2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2019-2024)
2.4 Traveler's Diarrhea Therapeutics Segment by Application
2.4.1 Adult Traveler's Diarrhea
2.4.2 Children Traveler's Diarrhea
2.5 Traveler's Diarrhea Therapeutics Sales by Application
2.5.1 Global Traveler's Diarrhea Therapeutics Sale Market Share by Application (2019-2024)
2.5.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2019-2024)
3 Global Traveler's Diarrhea Therapeutics by Company
3.1 Global Traveler's Diarrhea Therapeutics Breakdown Data by Company
3.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Company (2019-2024)
3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2019-2024)
3.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Company (2019-2024)
3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Company (2019-2024)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2019-2024)
3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Company
3.4 Key Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Traveler's Diarrhea Therapeutics Product Location Distribution
3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Traveler's Diarrhea Therapeutics by Geographic Region
4.1 World Historic Traveler's Diarrhea Therapeutics Market Size by Geographic Region (2019-2024)
4.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Traveler's Diarrhea Therapeutics Market Size by Country/Region (2019-2024)
4.2.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Traveler's Diarrhea Therapeutics Sales Growth
4.4 APAC Traveler's Diarrhea Therapeutics Sales Growth
4.5 Europe Traveler's Diarrhea Therapeutics Sales Growth
4.6 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Growth
5 Americas
5.1 Americas Traveler's Diarrhea Therapeutics Sales by Country
5.1.1 Americas Traveler's Diarrhea Therapeutics Sales by Country (2019-2024)
5.1.2 Americas Traveler's Diarrhea Therapeutics Revenue by Country (2019-2024)
5.2 Americas Traveler's Diarrhea Therapeutics Sales by Type
5.3 Americas Traveler's Diarrhea Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Traveler's Diarrhea Therapeutics Sales by Region
6.1.1 APAC Traveler's Diarrhea Therapeutics Sales by Region (2019-2024)
6.1.2 APAC Traveler's Diarrhea Therapeutics Revenue by Region (2019-2024)
6.2 APAC Traveler's Diarrhea Therapeutics Sales by Type
6.3 APAC Traveler's Diarrhea Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Traveler's Diarrhea Therapeutics by Country
7.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2019-2024)
7.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2019-2024)
7.2 Europe Traveler's Diarrhea Therapeutics Sales by Type
7.3 Europe Traveler's Diarrhea Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Country
8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2019-2024)
8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type
8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Traveler's Diarrhea Therapeutics
10.3 Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics
10.4 Industry Chain Structure of Traveler's Diarrhea Therapeutics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Traveler's Diarrhea Therapeutics Distributors
11.3 Traveler's Diarrhea Therapeutics Customer
12 World Forecast Review for Traveler's Diarrhea Therapeutics by Geographic Region
12.1 Global Traveler's Diarrhea Therapeutics Market Size Forecast by Region
12.1.1 Global Traveler's Diarrhea Therapeutics Forecast by Region (2025-2030)
12.1.2 Global Traveler's Diarrhea Therapeutics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Traveler's Diarrhea Therapeutics Forecast by Type
12.7 Global Traveler's Diarrhea Therapeutics Forecast by Application
13 Key Players Analysis
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
13.2 P&G
13.2.1 P&G Company Information
13.2.2 P&G Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 P&G Main Business Overview
13.2.5 P&G Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Otsuka Pharma
13.4.1 Otsuka Pharma Company Information
13.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Otsuka Pharma Main Business Overview
13.4.5 Otsuka Pharma Latest Developments
13.5 Valneva
13.5.1 Valneva Company Information
13.5.2 Valneva Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Valneva Main Business Overview
13.5.5 Valneva Latest Developments
13.6 Shanghai United Cell
13.6.1 Shanghai United Cell Company Information
13.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shanghai United Cell Main Business Overview
13.6.5 Shanghai United Cell Latest Developments
13.7 PaxVax
13.7.1 PaxVax Company Information
13.7.2 PaxVax Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 PaxVax Main Business Overview
13.7.5 PaxVax Latest Developments
13.8 Livzon
13.8.1 Livzon Company Information
13.8.2 Livzon Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Livzon Main Business Overview
13.8.5 Livzon Latest Developments
13.9 Immuron
13.9.1 Immuron Company Information
13.9.2 Immuron Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Immuron Main Business Overview
13.9.5 Immuron Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Traveler's Diarrhea Therapeutics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Traveler's Diarrhea Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Immunization
Table 4. Major Players of Non-antibiotic Agents
Table 5. Major Players of Antibiotics
Table 6. Major Players of Anti-Motility Agents
Table 7. Major Players of Others
Table 8. Global Traveler's Diarrhea Therapeutics Sales by Type (2019-2024) & (K Units)
Table 9. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2024)
Table 10. Global Traveler's Diarrhea Therapeutics Revenue by Type (2019-2024) & ($ million)
Table 11. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2019-2024)
Table 12. Global Traveler's Diarrhea Therapeutics Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Traveler's Diarrhea Therapeutics Sales by Application (2019-2024) & (K Units)
Table 14. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2019-2024)
Table 15. Global Traveler's Diarrhea Therapeutics Revenue by Application (2019-2024)
Table 16. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2019-2024)
Table 17. Global Traveler's Diarrhea Therapeutics Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Traveler's Diarrhea Therapeutics Sales by Company (2019-2024) & (K Units)
Table 19. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2019-2024)
Table 20. Global Traveler's Diarrhea Therapeutics Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2019-2024)
Table 22. Global Traveler's Diarrhea Therapeutics Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution and Sales Area
Table 24. Players Traveler's Diarrhea Therapeutics Products Offered
Table 25. Traveler's Diarrhea Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Traveler's Diarrhea Therapeutics Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Traveler's Diarrhea Therapeutics Sales Market Share Geographic Region (2019-2024)
Table 30. Global Traveler's Diarrhea Therapeutics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Traveler's Diarrhea Therapeutics Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Traveler's Diarrhea Therapeutics Sales Market Share by Country/Region (2019-2024)
Table 34. Global Traveler's Diarrhea Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Traveler's Diarrhea Therapeutics Sales by Country (2019-2024) & (K Units)
Table 37. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Country (2019-2024)
Table 38. Americas Traveler's Diarrhea Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2019-2024)
Table 40. Americas Traveler's Diarrhea Therapeutics Sales by Type (2019-2024) & (K Units)
Table 41. Americas Traveler's Diarrhea Therapeutics Sales by Application (2019-2024) & (K Units)
Table 42. APAC Traveler's Diarrhea Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Region (2019-2024)
Table 44. APAC Traveler's Diarrhea Therapeutics Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. APAC Traveler's Diarrhea Therapeutics Sales by Type (2019-2024) & (K Units)
Table 47. APAC Traveler's Diarrhea Therapeutics Sales by Application (2019-2024) & (K Units)
Table 48. Europe Traveler's Diarrhea Therapeutics Sales by Country (2019-2024) & (K Units)
Table 49. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2019-2024)
Table 50. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2019-2024)
Table 52. Europe Traveler's Diarrhea Therapeutics Sales by Type (2019-2024) & (K Units)
Table 53. Europe Traveler's Diarrhea Therapeutics Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Traveler's Diarrhea Therapeutics
Table 61. Key Market Challenges & Risks of Traveler's Diarrhea Therapeutics
Table 62. Key Industry Trends of Traveler's Diarrhea Therapeutics
Table 63. Traveler's Diarrhea Therapeutics Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Traveler's Diarrhea Therapeutics Distributors List
Table 66. Traveler's Diarrhea Therapeutics Customer List
Table 67. Global Traveler's Diarrhea Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Traveler's Diarrhea Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Traveler's Diarrhea Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Traveler's Diarrhea Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Traveler's Diarrhea Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Traveler's Diarrhea Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Traveler's Diarrhea Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Salix Pharmaceuticals Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 82. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 83. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Salix Pharmaceuticals Main Business
Table 85. Salix Pharmaceuticals Latest Developments
Table 86. P&G Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 87. P&G Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 88. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. P&G Main Business
Table 90. P&G Latest Developments
Table 91. Johnson & Johnson Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 92. Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 93. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Johnson & Johnson Main Business
Table 95. Johnson & Johnson Latest Developments
Table 96. Otsuka Pharma Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 97. Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 98. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Otsuka Pharma Main Business
Table 100. Otsuka Pharma Latest Developments
Table 101. Valneva Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 102. Valneva Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 103. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Valneva Main Business
Table 105. Valneva Latest Developments
Table 106. Shanghai United Cell Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 107. Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 108. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Shanghai United Cell Main Business
Table 110. Shanghai United Cell Latest Developments
Table 111. PaxVax Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 112. PaxVax Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 113. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. PaxVax Main Business
Table 115. PaxVax Latest Developments
Table 116. Livzon Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 117. Livzon Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 118. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Livzon Main Business
Table 120. Livzon Latest Developments
Table 121. Immuron Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 122. Immuron Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
Table 123. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Immuron Main Business
Table 125. Immuron Latest Developments
List of Figures
Figure 1. Picture of Traveler's Diarrhea Therapeutics
Figure 2. Traveler's Diarrhea Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Traveler's Diarrhea Therapeutics Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Traveler's Diarrhea Therapeutics Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Traveler's Diarrhea Therapeutics Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Immunization
Figure 10. Product Picture of Non-antibiotic Agents
Figure 11. Product Picture of Antibiotics
Figure 12. Product Picture of Anti-Motility Agents
Figure 13. Product Picture of Others
Figure 14. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2023
Figure 15. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2019-2024)
Figure 16. Traveler's Diarrhea Therapeutics Consumed in Adult Traveler's Diarrhea
Figure 17. Global Traveler's Diarrhea Therapeutics Market: Adult Traveler's Diarrhea (2019-2024) & (K Units)
Figure 18. Traveler's Diarrhea Therapeutics Consumed in Children Traveler's Diarrhea
Figure 19. Global Traveler's Diarrhea Therapeutics Market: Children Traveler's Diarrhea (2019-2024) & (K Units)
Figure 20. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2023)
Figure 21. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application in 2023
Figure 22. Traveler's Diarrhea Therapeutics Sales Market by Company in 2023 (K Units)
Figure 23. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2023
Figure 24. Traveler's Diarrhea Therapeutics Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company in 2023
Figure 26. Global Traveler's Diarrhea Therapeutics Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Traveler's Diarrhea Therapeutics Sales 2019-2024 (K Units)
Figure 29. Americas Traveler's Diarrhea Therapeutics Revenue 2019-2024 ($ Millions)
Figure 30. APAC Traveler's Diarrhea Therapeutics Sales 2019-2024 (K Units)
Figure 31. APAC Traveler's Diarrhea Therapeutics Revenue 2019-2024 ($ Millions)
Figure 32. Europe Traveler's Diarrhea Therapeutics Sales 2019-2024 (K Units)
Figure 33. Europe Traveler's Diarrhea Therapeutics Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Traveler's Diarrhea Therapeutics Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue 2019-2024 ($ Millions)
Figure 36. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2023
Figure 37. Americas Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2023
Figure 38. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2024)
Figure 39. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Application (2019-2024)
Figure 40. United States Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Region in 2023
Figure 45. APAC Traveler's Diarrhea Therapeutics Revenue Market Share by Regions in 2023
Figure 46. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2024)
Figure 47. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Application (2019-2024)
Figure 48. China Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2023
Figure 56. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2023
Figure 57. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2024)
Figure 58. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application (2019-2024)
Figure 59. Germany Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application (2019-2024)
Figure 68. Egypt Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Traveler's Diarrhea Therapeutics Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Traveler's Diarrhea Therapeutics in 2023
Figure 74. Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics
Figure 75. Industry Chain Structure of Traveler's Diarrhea Therapeutics
Figure 76. Channels of Distribution
Figure 77. Global Traveler's Diarrhea Therapeutics Sales Market Forecast by Region (2025-2030)
Figure 78. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Application (2025-2030)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
